G-PEN TM(GLUCAGON INJECTION) COMPARED TO LILLY GLUCAGON (GLUCAGON FOR INJECTION [RDNA ORIGIN]) FOR INDUCED HYPOGLYCEMIA RESCUE IN ADULT PATIENTS WITH T1D: A PHASE 3B MULTI-CENTERED, RANDOMIZED, CONTROLLED, SINGLE BLIND, 2-WAY CROSSOVER STUDY TO EVALUATE EFFICACY AND SAFETY
- Registry ID
- XSGP-303
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- XERIS PHARMACEUTICALS INC
- Start date
- 2018-03-05
- Completion date
- 2018-05-31
- Last update
- 2018-01-16
Conditions
Related clinical trials
- A PHASE 1/2 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF VX-880 IN SUBJECTS WHO HAVE TYPE 1 DIABETES MELLITUS WITH IMPAIRED HYPOGLYCEMIC AWARENESS AND SEVERE HYPOGLYCEMIA
- AN OPEN-LABEL, FIRST-IN-HUMAN, STUDY EVALUATING THE SAFETY,TOLERABILITY, AND EFFICACY OF VC-02 COMBINATION PRODUCT IN SUBJECTS WITH TYPE 1 DIABETES MELLITUS AND HYPOGLYCEMIA UNAWARENESS
- A ONE-YEAR, MULTICENTER, NON-INTERVENTIONAL, FOLLOW-UP, SAFETY STUDY IN SUBJECTS PREVIOUSLY IMPLANTED WITH VC-02 COMBINATION PRODUCT
View on source registry